Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Avonex
Active Ingredient(s): Interferon beta-1a 30µg
Dosage Form: Powder for injection
New Zealand Sponsor: CSL (New Zealand) Limited
Manufacturer(s): Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Pierre Fabre Medicament Production Etablissement Aquitaine Pharm International, Idron, France
Dated this 2nd day of August 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).